Enanta Pharmaceuticals Inc (ENTA) — Long-term Investment Intensity
Enanta Pharmaceuticals Inc (ENTA) has a Long-term Investment Intensity of 17.0% as of December 2025. Long-term investments of $56.05 Million represent 17.0% of total assets of $329.50 Million. A higher ratio indicates a company with significant capital committed to long-duration strategic positions. See Enanta Pharmaceuticals Inc book value and equity for net asset value and shareholders' equity analysis.
LT Investment Intensity
Long-term Investments
Total Assets
Country
Enanta Pharmaceuticals Inc Long-term Investment Intensity (2014–2022)
This chart shows how Enanta Pharmaceuticals Inc's Long-term Investment Intensity has evolved across 9 annual periods from 2014 to 2022. As of December 2025, the intensity stands at 17.0%, reflecting long-term investments of $56.05 Million against total assets of $329.50 Million USD. Also explore total assets of Enanta Pharmaceuticals Inc for the complete picture of this company's asset base.
Annual Long-term Investment Intensity for Enanta Pharmaceuticals Inc (2014–2022)
The table below presents the year-by-year Long-term Investment Intensity for Enanta Pharmaceuticals Inc from 2014 to 2022, covering 9 annual filings. Each row shows total assets, long-term investments, the intensity percentage, and the change in percentage points compared to the prior year. For market capitalisation and broader financial context, see Enanta Pharmaceuticals Inc (ENTA) total market value.
| Year | LT Investment Intensity | LT Investments (USD) | Total Assets | Change (pp) |
|---|---|---|---|---|
| 2022 | 7.7% | $29.29 Million | $380.59 Million | ▼ -16.9 pp |
| 2021 | 24.6% | $108.42 Million | $440.86 Million | ▲ +17.9 pp |
| 2020 | 6.6% | $32.63 Million | $490.79 Million | ▼ -6.6 pp |
| 2019 | 13.3% | $65.01 Million | $489.83 Million | ▲ +9.3 pp |
| 2018 | 4.0% | $16.39 Million | $414.23 Million | ▼ -17.5 pp |
| 2017 | 21.4% | $70.04 Million | $326.64 Million | ▲ +10.0 pp |
| 2016 | 11.4% | $32.12 Million | $281.28 Million | ▼ -14.7 pp |
| 2015 | 26.1% | $64.24 Million | $246.01 Million | ▼ -0.3 pp |
| 2014 | 26.4% | $41.00 Million | $155.41 Million | — |